Literature DB >> 11755269

Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages.

N Schöler1, H Hahn, R H Müller, O Liesenfeld.   

Abstract

Solid lipid nanoparticles (SLN) interact with mononuclear cells following intravenous injection. Little is known about the interaction of SLN with these cells, including cytotoxic effects and a possible up-regulation of pro-inflammatory cytokines. Therefore, we investigated the influence of lipid matrix, concentration, and size of SLN on murine peritoneal macrophages (mphi). mphi were incubated with SLN consisting of different lipid matrices and coated with the same surfactant. Cytotoxicity as assessed by MTT test was found to be concentration-dependent and was dramatically influenced by the lipid matrix. Marked cytotoxic effects were observed when cells were incubated with SLN consisting of stearic acid (STE) or dimethyl-dioctadecylammonium bromide (DDA) at concentrations of 0.01%, whereas SLN consisting of triglycerides, cetylpalmitate or paraffin did not exert major cytotoxic effects at the same concentrations. Cytotoxic effects were most likely caused by products of enzymatic degradation including free stearic acid. Analysis of cytokine production by mphi following incubation with SLN revealed concentration-dependent decreases in IL-6 production. These decreases seemed to be associated with cytotoxic effects. IL-12 and TNF-alpha production was neither detected in supernatants of mphi treated with SLN at any concentration nor in those of untreated cells. The size of SLN did neither affect cytotoxicity of SLN nor resulted in induction or digression of cytokine production by mphi. In conclusion, results of the present study revealed that the nature of the lipid matrix and the concentration of SLN dramatically impact cytotoxicity of SLN on mononuclear cells. Lipid matrices of SLN should therefore be carefully chosen and tested for later intravenous use.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11755269     DOI: 10.1016/s0378-5173(01)00882-1

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  14 in total

Review 1.  Nanoparticles and the immune system.

Authors:  Banu S Zolnik; Africa González-Fernández; Nakissa Sadrieh; Marina A Dobrovolskaia
Journal:  Endocrinology       Date:  2009-12-16       Impact factor: 4.736

2.  Structural organisation of cationic dioctadecyldimethyammonium bromide monolayers in presence of hyaluronic acid.

Authors:  R Ionov; A El-Abed; M Goldmann
Journal:  Eur Biophys J       Date:  2008-10-07       Impact factor: 1.733

3.  Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices.

Authors:  Santiswarup Singha; Kun Shao; Yang Yang; Xavier Clemente-Casares; Patricia Solé; Antonio Clemente; Jesús Blanco; Qin Dai; Fayi Song; Shang Wan Liu; Jun Yamanouchi; Channakeshava Sokke Umeshappa; Roopa Hebbandi Nanjundappa; Pascal Detampel; Matthias Amrein; César Fandos; Robert Tanguay; Susan Newbigging; Pau Serra; Anmar Khadra; Warren C W Chan; Pere Santamaria
Journal:  Nat Nanotechnol       Date:  2017-04-24       Impact factor: 39.213

4.  Multiple Lipid Nanoparticles (MLN), a New Generation of Lipid Nanoparticles for Drug Delivery Systems: Lamivudine-MLN Experimental Design.

Authors:  Suellen M T Cavalcanti; Cláudia Nunes; Sofia A C Lima; José L Soares-Sobrinho; Salette Reis
Journal:  Pharm Res       Date:  2017-03-17       Impact factor: 4.200

5.  Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research.

Authors:  Dinesh Kumar Mishra; Vinod Dhote; Punit Bhatnagar; Pradyumna Kumar Mishra
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

6.  In vivo biodistribution, anti-inflammatory, and hepatoprotective effects of liver targeting dexamethasone acetate loaded nanostructured lipid carrier system.

Authors:  Min-ting Wang; Yun Jin; Yun-xia Yang; Chun-yan Zhao; Hong-yun Yang; Xue-fan Xu; Xuan Qin; Zhao-dan Wang; Zhi-rong Zhang; Yan-lin Jian; Yuan Huang
Journal:  Int J Nanomedicine       Date:  2010-08-09

7.  Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.

Authors:  Patrícia Severino; Tatiana Andreani; Ana Sofia Macedo; Joana F Fangueiro; Maria Helena A Santana; Amélia M Silva; Eliana B Souto
Journal:  J Drug Deliv       Date:  2011-11-24

8.  Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles.

Authors:  Shuyu Xie; Fenghua Wang; Yan Wang; Luyan Zhu; Zhao Dong; Xiaofang Wang; Xihe Li; Wenzhong Zhou
Journal:  Part Fibre Toxicol       Date:  2011-11-20       Impact factor: 9.400

Review 9.  Stimulating antitumor immunity with nanoparticles.

Authors:  Mee Rie Sheen; Patrick H Lizotte; Seiko Toraya-Brown; Steven Fiering
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-05-21

10.  Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages.

Authors:  Antonina Orlando; Francesca Re; Silvia Sesana; Ilaria Rivolta; Alice Panariti; Davide Brambilla; Julien Nicolas; Patrick Couvreur; Karine Andrieux; Massimo Masserini; Emanuela Cazzaniga
Journal:  Int J Nanomedicine       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.